FXR1 and cancer: Moreover, melanoma cells with Fbxo4I377M mutation also exhibit increased Fxr1 levels (Supplementary Fig. 10b–d), consistent with Fbxo4-dependent regulation of Fxr1 in normal cells, and the disruption of this pathway in human cancers.